Medivation Inc (MDVN)

pos +0.02
Today's Range: 81.43 - 81.48 | MDVN Avg Daily Volume: 4,259,000
Last Update: 09/27/16 - 4:14 PM EDT
Volume: 7,203,016
YTD Performance: 68.47%
Open: $81.44
Previous Close: $81.42
52 Week Range: $26.41 - $63.35
Oustanding Shares: 165,928,674
Market Cap: 13,513,231,211
6-Month Chart
TheStreet Ratings Grade for MDVN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 3 9 9
Moderate Buy 0 0 0 0
Hold 11 11 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.69 2.57 1.62 1.62
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -79.07
Price Earnings Comparisons:
MDVN Sector Avg. S&P 500
-79.07 54.10 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
43.86% 95.58% 173.52%
Revenue 32.80 4.20 0.72
Net Income -11.50 -6.90 0.00
EPS -14.00 -6.50 0.00
Earnings for MDVN:
Revenue 0.94B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $0.30 $0.43 $1.00 $1.56
Number of Analysts 4 4 5 1
High Estimate $0.33 $0.50 $1.11 $1.56
Low Estimate $0.25 $0.31 $0.83 $1.56
Prior Year $0.27 $0.21 $0.68 $1.00
Growth Rate (Year over Year) 10.19% 103.57% 46.76% 56.31%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Despite markets at record highs, companies are satisfying their appetites to grow and find value by buying others.
Pfizer's second acquisition this week could add risk. Some retailers attract portfolio managers.
Stocks travel a good distance just to end up nowhere.
It was nice to fill in for Doug Kass on what was a very uneventful Monday to begin the week. The market traded in an extremely narrow range for the day, and outside the strength in biotech and the weakness in oil after a nice recent rally there really wasn't much of note that happened today. Still, there were some good conversations on the Daily Dairy despite the directionless market.
Markets continue to trade in a very narrow range and remain largely directionless.
That's the hot spot in M&A right now.
Stocks are back to flat to slightly lower overall, but biotechs are up some 1.5% following the announcement from Pfizer (PFE) of plans to buy Medivation (MDVN) for $14 billion.
Overall, this is still a good environment for stock picking.
Las Vegas Sands (LVS) continues to show strength after Bank of America/Merrill Lynch put out an optimistic note this morning about Macau gambling. Energy is weak in early trading. Oil has drifted back down to around $47 a barrel following its recent roughly 20% rally.
Pfizer agrees to acquire Medivation while Citi puts Foot Locker and Under Armour on the back-to-school shopping list.

Columnist Conversations

we saw decent numbers from mr softie, our calls up nicely. We'll roll up. SOLD MSFT DEC 55 CAL...
we have a stellar winner here, will sell it and move on. SECOND this week! SOLD NFLX NOV 120 CALL AT ...
UK-based Manpower Group (MAN) reported better than expected Q3 earnings, at $1.87 versus a $1.72 estimate. ...
Join me for a very exclusive webinar with the amazing Mark Mahaney, from RBC Capital Markets.  Mark is on...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.